Report Categories
View AllRecent Articles
View All
ELA Envela Corporation delivers huge Q4 2025 EPS beat shares rise three percent amid positive investor sentiment
Exponent EXPO Stock Is It Testing Key Levels Steady Decline 20260427
What Coterra CTRA has done differently this quarter Coterra Misses EPS Estimates by 206 on Headwinds
What Ventas VTR management said that matters most Q1 2026 EPS Misses Estimates
Algonquin AQN Q1 2026 Earnings Beat Revenue NA EPS 013
AMC Ent AMC Slides 261 as Selling Pressure Mounts 20260515
Inflation Surges to ThreeYear High Reshaping Economic Outlook
AI Could Deter Future Tech Workers Raspberry Pi Founder Warns
Morgan Stanley Cuts Edison International Price Target to 64 Citing April Utility Sector Weakness
Managing Director Uses Everyday Purchases to Instill Financial Literacy in Children
Dropbox CEO Drew Houston to Step Down After 19 Years Transition to Executive Chairman
Consumer Prices Rise 38 in April Exceeding Expectations and Marking Highest Inflation Since May 2023
AI Economy Reshapes Labor Market BlueCollar Workers Could Emerge as Key Beneficiaries
Diversified Energy Expands Permian Footprint Through Maverick Natural Resources Acquisition
ALHC Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency
DXC Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 293
Carlyle Credit Income Fund CCID Q1 2026 Earnings EPS Misses Estimates by 317 Shares Edge Lower
Central Garden Pet Company CENTA Q1 2026 Earnings Earnings Beat Driven by Operational Discipline Amid Mixed TopLine Signals
RingCentral Q1 2026 Earnings EPS Beats Estimates as Stock Rises 313
FCRX Q1 2026 Earnings Slight EPS Miss Reflects Steady Performance Amid Stable Market Conditions
Electromed Inc ELMD Holds Steady Near Resistance as Traders Eye Key Levels
Coastal Financial Corporation CCB Gains Ground Testing Key Resistance Levels
LouisianaPacific LPX Surges 424 as Building Materials Sector Gathers Momentum
Crane Harbor Acquisition Corp Units CHACU Tumble Over 10 Key Support Tested Amid Selling Pressure
Inhibikase Therapeutics IKT Recovers 35 as Buyers Defend Key Support Level